Federal Circuit Affirms RMMS’s Non-Infringement Victory Involving Generic Doxycycline Capsules Small Molecules December 6, 2024 Read More
RMMS Scores Jury Win for Fresenius Kabi USA, LLC in Calcium Gluconate Trial Announcements August 30, 2024 Read More
RMMS Secures Non-Infringement Win on ZTLido® (lidocaine topical system) 1.8% Small Molecules August 27, 2024 Read More
RMMS Again Recognized by Chambers & Partners – RMMS, William Rakoczy Ranked Nationally for Life Sciences, Paul Molino Ranked for Illinois – Intellectual Property Awards & Recognition June 6, 2024 Read More
RMMS Receives Continued Recognition in IAM Patent 1000 – Seven Firm Partners Individually Recognized Awards & Recognition June 5, 2024 Read More
RMMS Defeats TRO/PI Motion on ORACEA® (doxycycline) Capsules Small Molecules April 11, 2024 Read More
RMMS Secures Non-Infringement Win on ORACEA® (doxycycline) Capsules Small Molecules April 1, 2024 Read More
RMMS, Paul Molino Recognized by Managing Intellectual Property on their 2024 Shortlists Awards & Recognition February 23, 2024 Read More
RMMS Notches Additional IPR Victories Related To Aflibercept Dosing Patents BiologicsPTAB January 19, 2024 Read More
RMMS Secures Invalidity Win on MYRBETRIQ® (mirabegron extended-release) Tablets, 25 and 50 mg Small Molecules June 9, 2023 Read More
RMMS Shortlisted for the “Firm of the Year – Life Sciences IP Litigation” by Managing Intellectual Property Awards & Recognition March 8, 2023 Read More
RMMS Receives Continued Recognition in IAM Patent 1000 – Two Firm Partners Individually Ranked Awards & Recognition July 6, 2022 Read More
RMMS Ranked Nationally for Life Sciences IP – William Rakoczy Again Recognized as IP Star Awards & Recognition June 15, 2022 Read More
RMMS Again Recognized by Chambers & Partners – RMMS, William Rakoczy Ranked Nationally for Life Sciences Awards & Recognition June 3, 2022 Read More
Federal Circuit Affirms Judgment Involving DUEXIS® Tablets (800 mg ibuprofen and 26.6 mg famotidine Small Molecules November 16, 2021 Read More
RMMS Secures Non-Infringement and Invalidity Win on BROMSITE® (bromfenac ophthalmic solution) 0.075% Small Molecules October 1, 2021 Read More
RMMS Expands Life Science Team with Addition of Kevin Warner Announcements September 9, 2021 Read More